Rainer Christine

Rainer Christine is the Managing Partner at Earlybird Venture Capital. In addition, Rainer serves as a Private Investor at Samplix and Biofidelity. Rainer is also a Board Member at Sense Biodetection Ltd, Oviva, Noscendo GmbH, CryoTherapeutics, and AYOXXA Biosystems GmbH. Rainer is the former CEO & Co-Founder of amaxa AG/amaxa Inc., where Earlybird was a seed investor. Rainer has a background in developing and commercializing Nucleofector technology for cell transfection. Rainer is an alum of the University of Cologne and the University of Sussex.